Ovarian Cancer Clinical Trial

Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

Summary

This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.

View Full Description

Full Description

PRIMARY OBJECTIVES:

I. To collect, both prospectively and retrospectively, data on disease characterization, treatment, and outcomes for approximately 1600 female patients with low-grade ovarian and peritoneal tumors.

II. To organize clinical information in order to support multifaceted queries of patient characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with patient outcome.

III. To have a single data repository, kept on a secure platform that will integrate clinical information and research findings and serve as a secure archive for future research.

SECONDARY OBJECTIVE:

I. To obtain and store human tumor samples in the form of blocks or slides for the purpose of establishing a tumor bank.

OUTLINE:

Patients' medical records are reviewed for retrospective and prospective data collection. Patients may also have residual tissue samples collected and stored.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis:

Ovarian tumor of low malignant potential
Low-grade serous carcinoma of the ovary
Primary peritoneal tumor of low malignant potential
Low-grade serous carcinoma of the peritoneum
Psammocarcinoma

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

2000

Study ID:

NCT00488878

Recruitment Status:

Recruiting

Sponsor:

M.D. Anderson Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

M D Anderson Cancer Center
Houston Texas, 77030, United States More Info
David M. Gershenson
Contact
713-563-4535
David M. Gershenson
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

2000

Study ID:

NCT00488878

Recruitment Status:

Recruiting

Sponsor:


M.D. Anderson Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.